Subcutaneous interferon alfa for the treatment of cutaneous pseudolymphoma.
Publication
, Journal Article
Singletary, HL; Selim, MA; Olsen, E
Published in: Arch Dermatol
May 2012
Duke Scholars
Published In
Arch Dermatol
DOI
EISSN
1538-3652
Publication Date
May 2012
Volume
148
Issue
5
Start / End Page
572 / 574
Location
United States
Related Subject Headings
- Skin Diseases
- Pseudolymphoma
- Interferon-alpha
- Injections, Subcutaneous
- Immunologic Factors
- Humans
- Follow-Up Studies
- Flow Cytometry
- Female
- Diagnosis, Differential
Citation
APA
Chicago
ICMJE
MLA
NLM
Singletary, H. L., Selim, M. A., & Olsen, E. (2012). Subcutaneous interferon alfa for the treatment of cutaneous pseudolymphoma. Arch Dermatol, 148(5), 572–574. https://doi.org/10.1001/archdermatol.2011.1016
Singletary, Holly Leigh, M Angelica Selim, and Elise Olsen. “Subcutaneous interferon alfa for the treatment of cutaneous pseudolymphoma.” Arch Dermatol 148, no. 5 (May 2012): 572–74. https://doi.org/10.1001/archdermatol.2011.1016.
Singletary HL, Selim MA, Olsen E. Subcutaneous interferon alfa for the treatment of cutaneous pseudolymphoma. Arch Dermatol. 2012 May;148(5):572–4.
Singletary, Holly Leigh, et al. “Subcutaneous interferon alfa for the treatment of cutaneous pseudolymphoma.” Arch Dermatol, vol. 148, no. 5, May 2012, pp. 572–74. Pubmed, doi:10.1001/archdermatol.2011.1016.
Singletary HL, Selim MA, Olsen E. Subcutaneous interferon alfa for the treatment of cutaneous pseudolymphoma. Arch Dermatol. 2012 May;148(5):572–574.
Published In
Arch Dermatol
DOI
EISSN
1538-3652
Publication Date
May 2012
Volume
148
Issue
5
Start / End Page
572 / 574
Location
United States
Related Subject Headings
- Skin Diseases
- Pseudolymphoma
- Interferon-alpha
- Injections, Subcutaneous
- Immunologic Factors
- Humans
- Follow-Up Studies
- Flow Cytometry
- Female
- Diagnosis, Differential